Early blood-brain barrier permeability in cerebella of PLSJL mice immunized with myelin basic protein

Journal of Neuroimmunology

Volumn 196, Issue 1-2, 2008, Pages 8-15

  Spitsin, Sergei ^a   Portocarrero, Carla ^a   Phares, Timothy W ^b   Kean, Rhonda B ^a   Brimer, Christine M ^a   Koprowski, Hilary ^c   Hooper, D Craig ^c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c NONE   (United States)

Author keywords

Blood brain barrier (BBB); Cerebellum; Experimental allergic encephalomyelitis (EAE); Multiple sclerosis (MS); Peroxynitrite (ONOO ); Uric acid (UA)

Indexed keywords

MYELIN BASIC PROTEIN; URIC ACID;

ALLERGIC ENCEPHALITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CEREBELLUM; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD; BLOOD-BRAIN BARRIER; CAPILLARY PERMEABILITY; CEREBELLUM; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FLUORESCEIN; GENE EXPRESSION REGULATION; INTERCELLULAR ADHESION MOLECULE-1; MACROPHAGE-1 ANTIGEN; MICE; MYELIN BASIC PROTEINS; NITRIC OXIDE SYNTHASE TYPE II; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 44349171084     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.02.004     Document Type: Article

References (29)

1. Archambault A.S., Sim J., McCandless E.E., Klein R.S., and Russell J.H. Region-specific regulation of inflammation and pathogenesis in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 181 1-2 (2006) 122-132
2. Archelos J.J., and Hartung H.P. Adhesion molecules in multiple sclerosis: a review. Frontiers in Multiple Sclerosis II (1999), Martin Dunitz Ltd, London 85-116
3. Brown K.A. Factors modifying the migration of lymphocytes across blood-brain barrier. Int. Immunopharmacol. 1 (2001) 2043-2062
4. Cross A.H., O'Mara T., and Raine C.S. Chronologic localization of myelin-reactive cells in the lesions of relapsing EAE: implications for the study of multiple sclerosis. Neurology 43 (1993) 1028-1033
5. - in inflammatory CNS demyelination. J. Neuroimmunol. 80 (1997) 121-130
6. Cross A.H., Maning P.T., Keeling R.M., Schmidt R.E., and Misko T.P. Peroxynitrite formation within the central nervous system in active multiple sclerosis. J. Neuroimmunol. 88 (1998) 45-56
7. Fabis M.J., Scott G.S., Kean R.B., Koprowski H., and Hooper D.C. Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models. Proc. Natl. Acad. Sci. U. S. A. 104 13 (2007) 5656-5661
8. Fazekas G., and Tabira T. What transgenic and knockout mouse models teach us about experimental autoimmune encephalomyelitis. Rev. Immunogenet. 2 (2000) 115-132
9. Hemmer B., Cepok S., Nessler S., and Sommer N. Pathogenesis of multiple sclerosis: an update on immunology. Curr. Opin. Neurol. 15 (2002) 227-231
10. -: implications for the treatment of multiple sclerosis. P. N. A. S. 94 (1997) 2528-2533
11. -, in experimental allergic encephalomyelitis and multiple sclerosis. P. N. A. S. 95 (1998) 675-680
12. Hooper D.C., Scott G.S., Zborek A., Mikheeva T., Kean R.B., Koprowski H., and Spitsin S.V. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J. 14 (2000) 691-698
13. Hooper D.C., Kean R.B., Scott G.S., Spitsin S.V., Morimoto K., Bette M., Röhrenbeck A.M., Dietzschold B., and Weihe E. The CNS inflammatory response to neurotropic virus infection is peroxynitrite-dependent. J. Immunol. 167 (2001) 3470-3477
14. Imitola J., Chitnis T., and Khoury S.J. Cytokines in multiple sclerosis: from bench to bedside. Pharmacol. Ther. 106 (2005) 163-177
15. Kean R.B., Spitsin S.V., Mikheeva T., Scott G.S., and Hooper D.C. The peroxynitrite scavenger uric acid prevents inflammatory cell invasion into the CNS in experimental allergic encephalomyelitis through maintenance of blood-CNS barrier integrity. J. Immunol. 165 (2000) 6511-6518
16. Kieseier B.C., Storch M.K., Archelos J.J., Martino G., and Hartung H.P. Effector pathways in immune mediated central nervous system demyelination. Curr. Opin. Neurol. 12 (1999) 323-336
17. Liu J.S.-H., Zhao M.-L., Brosnan C.F., and Lee S.C. Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am. J. Pathol. 158 (2001) 2057-2066
18. Muller D.M., Pendera M.P., and Greer J.M. Blood-brain barrier disruption and lesion localisation in experimental autoimmune encephalomyelitis with predominant cerebellar and brainstem involvement. J. Neuroimmunol. 160 (2005) 162-169
19. Pan W., Banks W.A., Kennedy M.K., Gutierrez E.G., and Kastin A.J. Differential permeability of the BBB in acute EAE: enhanced transport of TNT-alpha. Am. J. Physiol. 271 (1996) E636-E642
20. Phares T.W., Kean R.B., Mikheeva T., and Hooper D.C. Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J Immunol. 176 12 (2006) 7666-7675
21. Plebanski M., Saunders M., Burtles S.S., Crowe S., and Hooper D.C. Primary and secondary human in vitro T cell responses to soluble antigens are mediated by subsets bearing different CD45 isoforms. Immunology 75 (1992) 86-91
22. Scott G.S., Hake P., Kean R.B., Virág L., Szabó C., and Hooper D.C. Role of poly (ADP-ribose) synthetase activation in the development of experimental allergic encephalomyelitis. J. Neuroimmunol. 117 (2001) 78-86
23. Scott G.S., Kean R.B., Fabis M.J., Mikheeva T., Brimer C.M., Phares T.W., Spitsin S., and Hooper D.C. ICAM-1 upregulation in the spinal cords of PLSJL mice with experimental allergic encephalomyelitis is dependent upon TNF-a production triggered by the loss of blood-brain barrier integrity. J. Neuroimmunol. 155 (2004) 32-42
24. Silwedel C., and Förster C.J. Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli. J. Neuroimmunol. 179 (2006) 37-45
25. Simmons R.D., Bernard C.C., Singer G., and Carnegie P.R. Experimental autoimmune encephalomyelitis. An anatomically-based explanation of clinical progression in rodents. J Neuroimmunol. 3 (1982) 307-318
26. Smorodchenko A., Wuerfel J., Pohl E.E., Vogt J., Tysiak E., Glumm R., Hendrix S., Nitsch R., Zipp F., and Carmen Infante-Duarte C. CNS-irrelevant T-cells enter the brain, cause blood-brain barrier disruption but no glial pathology. Eur. J. Neurosci. 26 (2007) 1387-1398
27. Tonra J.R., Reiseter B.S., Kolbeck R., Nagashima K., Robertson R., Keyt B., and Lindsay R.M. Comparison of the timing of acute blood-brain barrier breakdown to rabbit immunoglobulin G in the cerebellum and spinal cord of mice with experimental autoimmune encephalomyelitis. J. Comp. Neurol. 430 (2001) 131-144
28. Tonra J.R. Cerebellar susceptibility to experimental autoimmune encephalomyelitis in SJL/J mice: potential interaction of immunology with vascular anatomy. Cerebellum 1 (2002) 57-68
29. - activity during progressive stages of central nervous system inflammation. J. Neuroimmunol. 77 (1997) 1-7